Vestal Point Capital, LP 13D and 13G filings for Lexeo Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Vestal Point Capital, LP | 4,117,302 7.500% | 889,141 (+27.54%) | Filing |
| 2025-08-14 3:51 pm Purchase | 2025-06-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Vestal Point Capital, LP | 3,228,161 6.000% | 3,228,161 (New Position) | Filing |